<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Rossier, Jeremie</dc:creator>
  <dc:creator>Hauser, Daniel</dc:creator>
  <dc:creator>Kottelat, Emmanuel</dc:creator>
  <dc:creator>Rothen-Rutishauser, Barbara</dc:creator>
  <dc:creator>Zobi, Fabio</dc:creator>
  <dc:date>2017-02-14</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Herein we report the synthesis of new water-soluble vitamin B12 prodrugs bearing  metal complexes at the β-upper side of the cobalt center. A total of three derivatives  with the general design {Co–C[triple bond, length as m-dash]C-bpy–M}, where M  represents a cytotoxic metal complex, were prepared and tested for their cytotoxicity  against MCF-7 breast cancer cells. The choice of the metal was oriented on the  eminent Pt and promising Ru and Re species to demonstrate the general applicability  of the approach. The recognition of the derivatives by transcobalamin was  demonstrated by competitive displacement assays using rhodamine labeled B12. This  compound further served to prepare a dual luminescent probe by orthogonal synthesis  with M = ((HCCbpy)Ru(bpy)2)Cl2 and to perform in vitro assays. Cellular imaging  experiments allowed us to observe the different compartmentalization of both dyes and  thus prove that the species follow the natural cobalamin uptake as well as the self- triggered release of the β-upper complex.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/305337</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/305337/files/zob_oca.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/305337/files/zob_oca_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1039/C6DT04443C</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Dalton Transactions. - 2017, vol. 46, no. 7, p. 2159–2164</dc:source>
  <dc:subject>info:eu-repo/classification/udc/54</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Organometallic cobalamin anticancer derivatives for targeted prodrug delivery via transcobalamin-mediated uptake</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
